ATRC (STOCKS)
AtriCure, Inc.
$27.980000
-0.810000 (-2.81%)
Prev close: $28.790000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael H. Carrel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,418.45M
- Employees
- 1,300
- P/E (TTM)
- -289.95
- P/B (TTM)
- 2.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $552.16M |
| Benefits Costs and Expenses | $555.42M |
| Cost Of Revenue | $134.70M |
| Costs And Expenses | $555.42M |
| Gross Profit | $417.46M |
| Operating Expenses | $420.43M |
| Selling, General, and Administrative Expenses | $319.51M |
| Research and Development | $100.92M |
| Operating Income/Loss | -$2.97M |
| Income/Loss From Continuing Operations After Tax | -$4.59M |
| Income/Loss From Continuing Operations Before Tax | -$3.26M |
| Income Tax Expense/Benefit | $1.33M |
| Net Income/Loss | -$4.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$4.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$4.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.10 |
| Diluted Earnings Per Share | -$0.10 |
| Basic Average Shares | 144,045,000 |
| Diluted Average Shares | 144,757,000 |
| Assets | $643.99M |
| Current Assets | $313.69M |
| Inventory | $81.14M |
| Other Current Assets | $232.55M |
| Noncurrent Assets | $330.30M |
| Intangible Assets | $45.64M |
| Other Non-current Assets | $284.65M |
| Liabilities | $152.30M |
| Current Liabilities | $73.19M |
| Accounts Payable | $30.56M |
| Wages | $32.25M |
| Other Current Liabilities | $10.38M |
| Noncurrent Liabilities | $79.10M |
| Long-term Debt | $61.00M |
| Other Non-current Liabilities | $18.10M |
| Equity | $491.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $491.69M |
| Liabilities And Equity | $643.99M |
| Net Cash Flow From Operating Activities | $64.36M |
| Net Cash Flow From Operating Activities, Continuing | $64.36M |
| Net Cash Flow From Investing Activities | -$16.72M |
| Net Cash Flow From Investing Activities, Continuing | -$16.72M |
| Net Cash Flow From Financing Activities | -$1.75M |
| Net Cash Flow From Financing Activities, Continuing | -$1.75M |
| Exchange Gains/Losses | $391.00K |
| Net Cash Flow | $46.28M |
| Net Cash Flow, Continuing | $45.89M |
| Comprehensive Income/Loss | -$4.14M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$4.14M |
| Other Comprehensive Income/Loss | -$4.14M |
| Other Comprehensive Income/Loss Attributable To Parent | $457.00K |